Here, we show that COPD subjects have increased IL-36γ and decreased IL-36 receptor antagonist (IL-36Ra) in bronchoalveolar and nasal fluid compared with control subjects. The gene discussed is IL1RL2; the disease is chronic obstructive pulmonary disease.